News

IMC Krems: Strahlkraft der OMICS-Technologien: Highlights vom Life Science Meeting 2025

CHE Ranking: IMC Krems in den Spitzengruppen

Meduni Vienna: Important step towards improving diagnosis and treatment of brain metastases

GSK: Öffentlich finanziertes Impfprogramm wird ausgebaut

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

AGES entwickelt und testet mobiles Hochsicherheitslabor

Ribbon Bio Launches MiroSynth™ DNA Molecules to Unlock a New Era of Complex Synthetic DNA

Meduni Vienna: Diabetes drug as a possible treatment for prostate cancer

Topcon Healthcare Acquires RetInSight to Accelerate AI-Powered Imaging Innovation in Eye Care

CD Laboratory for Chronic Inflammatory Skin Diseases opens at MedUni Vienna

Biomay Obtains FDA Approval for Manu­facturing of Cas9 Nuclease

University of Salzburg receives prestigious EU funding for innovative cancer research network

BOKU Wien: Neue Erkenntnisse über das molekulare Wettrüsten zwischen Pflanzen und Krankheitserregern

PHARMIG: Schutz des geistigen Eigentums stärkt Medikamentenentwicklung in Europa

PHARMIG: Impflücken als Gesundheitsrisiko

MedUni Vienna and University Hospital Vienna as pioneers in novel cell therapies

PHARMIG: TLife Sciences in Wien auf Erfolgskurs

Innovationsminister Hanke: "Stärkung der Forschungsquote hilft uns allen"